Nuvation Bio, Inc. (NUVB)
5.00
+0.05
(+1.01%)
USD |
NYSE |
Oct 09, 16:00
5.07
+0.07
(+1.40%)
After-Hours: 20:00
Nuvation Bio Total Return Level : 5.00 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 5.00 |
| October 08, 2026 | 4.95 |
| October 07, 2026 | 4.86 |
| October 06, 2026 | 4.88 |
| October 05, 2026 | 4.95 |
| October 02, 2026 | 5.14 |
| October 01, 2026 | 5.56 |
| September 30, 2026 | 5.60 |
| September 29, 2026 | 5.62 |
| September 28, 2026 | 5.60 |
| September 25, 2026 | 5.74 |
| September 24, 2026 | 5.73 |
| September 23, 2026 | 5.71 |
| September 22, 2026 | 6.10 |
| September 21, 2026 | 6.07 |
| September 18, 2026 | 5.85 |
| September 17, 2026 | 6.07 |
| September 16, 2026 | 5.78 |
| September 15, 2026 | 5.80 |
| September 14, 2026 | 5.94 |
| September 11, 2026 | 6.07 |
| September 10, 2026 | 6.28 |
| September 09, 2026 | 6.52 |
| September 08, 2026 | 6.61 |
| September 04, 2026 | 6.81 |
| Date | Value |
|---|---|
| September 03, 2026 | 6.77 |
| September 02, 2026 | 6.93 |
| September 01, 2026 | 6.64 |
| August 31, 2026 | 6.66 |
| August 28, 2026 | 6.66 |
| August 27, 2026 | 6.99 |
| August 26, 2026 | 6.96 |
| August 25, 2026 | 7.10 |
| August 24, 2026 | 6.76 |
| August 21, 2026 | 6.93 |
| August 20, 2026 | 6.83 |
| August 19, 2026 | 7.26 |
| August 18, 2026 | 6.96 |
| August 17, 2026 | 6.48 |
| August 14, 2026 | 6.22 |
| August 13, 2026 | 6.10 |
| August 12, 2026 | 6.42 |
| August 11, 2026 | 6.37 |
| August 10, 2026 | 6.60 |
| August 07, 2026 | 6.60 |
| August 06, 2026 | 6.11 |
| August 05, 2026 | 6.37 |
| August 04, 2026 | 6.44 |
| August 03, 2026 | 6.16 |
| July 31, 2026 | 6.33 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Bristol Myers Squibb Co. | 225.98 |
| Johnson & Johnson | 623.85 |
| Pfizer Inc. | 94.60 |
| Eli Lilly & Co. | 3115.88 |
| Merck & Co., Inc. | 450.25 |